DISCLOSEDQuarterly
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
1,380,248 sh · $1.9M
Filed 30 Jun 2026SEC 13Fview source
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
1,380,248 sh · $1.9M
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
241,188 sh · $323.2K
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
241,188 sh · $385.9K
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
241,188 sh · $617.4K
Oaktree Capital Management
Bioxcel Therapeutics Inc · NASDAQ
241,188 sh · $436.6K